SCHEMBL8027341

SCHEMBL8027341

Clc1ccc(-c2nc3ccc(Cl)cc3n2-c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
KDM4E B2RXH2 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
CYP1A2 P05177 1/20 0.60
GAA P10253 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
PTGS2 P35354 1/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
MAPT P10636 1/20 0.55
AOC3 Q16853 2/20 0.52
KCNH2 Q12809 1/20 0.52
LMNA P02545 1/20 0.51
ALDH1A1 P00352 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23024881 0.95 RAB9A (0.66) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL2323575 0.89 ESR1 (0.58) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL8022202 0.88 PTGS2 (0.69) RAB9ANPC1KDM4ECYP1A2CYP2C9
SCHEMBL23945235 0.87 PTGS2 (0.51) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL2330775 0.85 GLA (0.57) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL20776032 0.83 NPC1 (0.54) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL2328008 0.83 ESR1 (0.66) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL8024755 0.83 PTGS2 (0.75) RAB9ANPC1KDM4ECYP1A2CYP2C9
SCHEMBL3741438 0.82 PTGS2 (0.53) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL15481630 0.82 PTGS2 (0.70) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030992-A ANTAGONISTS FOR THE BINDING OF NEUROKININ-2 RECEPTOR; SLEEP DISORDERS; BENZIMIDES, 2- OR 3-ALKOXYBENZIMIDES AND 2,3-DIALKOXYBENZIMIDES ELI LILLY AND COMPANY (US) 2000-02-29 US disclosed
US-6025379-A A SUBSTITUTED BENZIMIDAZOLE, TACHYKININ RECEPTOR ANTAGONISTS, ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed
US-5552426-A NERVOUS SYSTEM DISORDERS USING IMIDAZOLE DERIVITIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0694535-A1 Non-peptidyl tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-01-31 EP disclosed